Moyamoya Angiopathy (MMA) is a rare, progressive, steno-occlusive cerebrovascular disorder. The disease can be idiopathic (Moyamoya Disease, MMD) or associated with heritable or acquired conditions (i.e., Moyamoya Syndrome, MMS). Among clinical symptoms of MMA, cognitive aspects are acknowledged but not well-characteri...
Serena Beretta, I. Scala, Isabella Canavero et al.· Neuropsychology Review· 0 citations
BACKGROUND AND OBJECTIVES
Iatrogenic cerebral amyloid angiopathy (iCAA), likely caused by transmission of amyloid-beta by medical procedures, is a rare but distinct cerebral amyloid angiopathy (CAA) subtype, with rising numbers of patients identified globally. However, given its relatively recent recognition, data on l...
S. Fandler-Höfler, Benedetta Storti, K. Kaushik et al.· Neurology· 0 citations
Background: Flow diverters (FDs) are widely used to treat intracranial aneurysms. Although effective, FD-related thrombosis or progressive stenosis may lead to acute or delayed cerebral hypoperfusion with significant neurological morbidity. Management options are limited when medical or endovascular rescue strategies f...
Alessandro Tozzi, V. Caldiera, G. Ganci et al.· Neurology International· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.